BioSpace News Archive

Lone Star Bio

Vizient Applauds FDA Plan to Improve Medical Device Cybersecurity

Vizient expressed support for the Agency’s proactive approach to cybersecurity that will enhance existing programs and processes, enable timely resolution of known safety issues, and encourage innovative technologies that are safer and more effective.

June 1, 2018
·
2 min read
Policy

KARL STORZ Awarded Video Laryngoscope Contract by Vizient

KARL STORZ Endoscopy-America, Inc. is pleased to announce that it has been awarded a three-year multi-source contract for its Video Laryngoscopes by Vizient, Inc.

June 1, 2018
·
3 min read
Galderma Global Study Reveals True Burden of Rosacea and Encourages Healthcare Professionals to Look ‘Beyond the visible’

Galderma released the findings of a global survey highlighting the need for dermatologists and doctors to proactively open a dialogue with patients about the true burden of rosacea and ways in which they can work together to achieve ‘clear’ (IGA 0) skin.

June 1, 2018
·
9 min read
Galderma Global Study Reveals True Burden of Rosacea and Encourages Healthcare Professionals to Look ‘Beyond the visible’ duiplicate

Galderma released the findings of a global survey highlighting the need for dermatologists and doctors to proactively open a dialogue with patients about the true burden of rosacea and ways in which they can work together to achieve ‘clear’ (IGA 0) skin.

June 1, 2018
·
8 min read
Drug Development

Lilly to Showcase New Data at Digestive Disease Week 2018 for Mirikizumab in Moderate-to-Severe Ulcerative Colitis

Eli Lilly and Company announced that it will present new data evaluating mirikizumab for the treatment of moderate-to-severe ulcerative colitis (UC) at Digestive Disease Week (DDW).

June 1, 2018
·
4 min read
Drug Development

Proteostasis Announces Presentations at the 41st European Cystic Fibrosis Society Conference

Proteostasis Therapeutics, Inc. announced that data from the Company’s CF clinical development programs will be presented during two panel presentations at the 41st European Cystic Fibrosis Society (ECFS) Conference.

June 1, 2018
·
7 min read
Innovating the Aging Experience

Canada’s seniors are not afraid of innovation and want the private sector to develop products and services that improve the aging experience, empower their independence and provide more choice.

June 1, 2018
·
4 min read
Genetown

Seres Therapeutics to Present at Two Upcoming June Conferences

A live audio webcast of each presentation will be available under the “Investors and Media” section of Seres’ website.

June 1, 2018
·
1 min read
Business

Intelligent Medical Objects (IMO) Announces Leadership Transition to Support Next Chapter of Growth and Innovation

Intelligent Medical Objects, Inc., announced today that Chairman, CEO and Co-Founder Frank Naeymi-Rad, PhD, MS, MBA, will transition from CEO to the new role of Chief Innovator and continue as Chairman of the Board of the company.

June 1, 2018
·
3 min read
Drug Development

Opdivo (nivolumab) Plus Low-Dose (1mg/kg) Yervoy (ipilimumab) Provided Significant and Sustained Health-Related Quality of Life Improvements in Intermediate- and Poor-Risk Patients with Advanced Renal Cell Carcinoma in CheckMate -214 Study

Opdivo plus low-dose Yervoy is the first and only FDA-approved Immuno-Oncology combination therapy for this patient population.

June 1, 2018
·
33 min read